Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Neisseria meningitidis serogroup C Protein slyX homolog (slyX) CSB-YP429360NEW
CSB-EP429360NEW
CSB-BP429360NEW
CSB-MP429360NEW
CSB-EP429360NEW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neisseria meningitidis serogroup C 3-demethylubiquinone-9 3-methyltransferase (ubiG) CSB-YP429361NEW
CSB-EP429361NEW
CSB-BP429361NEW
CSB-MP429361NEW
CSB-EP429361NEW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neisseria meningitidis serogroup C 10 kDa chaperonin (groS) CSB-YP429362NEW
CSB-EP429362NEW
CSB-BP429362NEW
CSB-MP429362NEW
CSB-EP429362NEW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neisseria meningitidis serogroup C SsrA-binding protein (smpB) CSB-YP429363NEW
CSB-EP429363NEW
CSB-BP429363NEW
CSB-MP429363NEW
CSB-EP429363NEW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neisseria meningitidis serogroup C ATP synthase gamma chain (atpG) CSB-YP429364NEW
CSB-EP429364NEW
CSB-BP429364NEW
CSB-MP429364NEW
CSB-EP429364NEW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neisseria meningitidis serogroup C ATP synthase epsilon chain (atpC) CSB-YP429365NEW
CSB-EP429365NEW
CSB-BP429365NEW
CSB-MP429365NEW
CSB-EP429365NEW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neisseria meningitidis serogroup C 3-oxoacyl-[acyl-carrier-protein] synthase 3 (fabH) CSB-YP429366NEW
CSB-EP429366NEW
CSB-BP429366NEW
CSB-MP429366NEW
CSB-EP429366NEW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neisseria meningitidis serogroup C Histidinol-phosphate aminotransferase (hisC) CSB-YP429367NEW
CSB-EP429367NEW
CSB-BP429367NEW
CSB-MP429367NEW
CSB-EP429367NEW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neisseria meningitidis serogroup C Tyrosine recombinase XerC (xerC) CSB-YP429368NEW
CSB-EP429368NEW
CSB-BP429368NEW
CSB-MP429368NEW
CSB-EP429368NEW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neisseria meningitidis serogroup C Formate--tetrahydrofolate ligase (fhs), partial CSB-YP429369NEW
CSB-EP429369NEW
CSB-BP429369NEW
CSB-MP429369NEW
CSB-EP429369NEW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neisseria meningitidis serogroup C Shikimate kinase (aroK) CSB-YP429370NEW
CSB-EP429370NEW
CSB-BP429370NEW
CSB-MP429370NEW
CSB-EP429370NEW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neisseria meningitidis serogroup C UPF0761 membrane protein NMCC_0461 (NMCC_0461), partial CSB-YP429371NEW1
CSB-EP429371NEW1
CSB-BP429371NEW1
CSB-MP429371NEW1
CSB-EP429371NEW1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neisseria meningitidis serogroup C 30S ribosomal protein S20 (rpsT) CSB-YP429372NEW
CSB-EP429372NEW
CSB-BP429372NEW
CSB-MP429372NEW
CSB-EP429372NEW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neisseria meningitidis serogroup C Quinolinate synthase A (nadA) CSB-YP429373NEW
CSB-BP429373NEW
CSB-MP429373NEW
CSB-EP429373NEW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neisseria meningitidis serogroup C Glutamyl-Q tRNA (Asp) synthetase CSB-YP429374NEW
CSB-EP429374NEW
CSB-BP429374NEW
CSB-MP429374NEW
CSB-EP429374NEW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neisseria meningitidis serogroup C Imidazole glycerol phosphate synthase subunit HisF (hisF) CSB-YP429375NEW
CSB-EP429375NEW
CSB-BP429375NEW
CSB-MP429375NEW
CSB-EP429375NEW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neisseria meningitidis serogroup C N utilization substance protein B homolog (nusB) CSB-YP429376NEW
CSB-EP429376NEW
CSB-BP429376NEW
CSB-MP429376NEW
CSB-EP429376NEW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neisseria meningitidis serogroup C UPF0756 membrane protein NMCC_1816 (NMCC_1816), partial CSB-YP429377NEW1
CSB-EP429377NEW1
CSB-BP429377NEW1
CSB-MP429377NEW1
CSB-EP429377NEW1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neisseria meningitidis serogroup C Threonine--tRNA ligase (thrS), partial CSB-YP429378NEW
CSB-EP429378NEW
CSB-BP429378NEW
CSB-MP429378NEW
CSB-EP429378NEW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neisseria meningitidis serogroup C HPr kinase/phosphorylase (hprK) CSB-YP429379NEW
CSB-EP429379NEW
CSB-BP429379NEW
CSB-MP429379NEW
CSB-EP429379NEW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>